2024 Clinical Trials Epilepsy 
Project CBD
APRIL 17, 2025
Clinical benefits? A May 2024 article in the International Journal of Molecular Sciences assesses efforts thus far using CBD to treat inflammatory pain (such as in arthritis) via transdermal delivery systems. New clinical trials are urgently needed, they repeat in a familiar refrain. 2024 , 25 , 5858. Lefebvre, .;
Cannabis Law Report
NOVEMBER 18, 2021
The global COVID-19 vaccine market is expected to grow to US$25 billion by 2024, and Latin America represents a substantial part. Oravax is also preparing to commence clinical trials in Israel.”. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.
Veriheal
NOVEMBER 7, 2024
In May 2024, the U.S. However, the rescheduling process is yet to be finalized, and although some optimistic advocates expected the decision to be fast-tracked before the November 2024 election, the fight for cannabis reform will not be won so quickly. THC content) under federal law, signaling a major shift in the U.S.
Expert insights. Personalized for you.
Let's personalize your content